CLINICAL_TRIALS
trial_result
· 2022-12-19
Clinical Trial Update: A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 trial update for combination treatments in advanced renal cell carcinoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Advanced Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-12-19